2013-08-14 – Page 3 – China Stock Advice

NFEC [NF Energyvingrp] 10-Q: TABLE OFNTENTS Page PART I – FINANCIAL INFORMATION

[TABLE OFNTENTS Page PART I - FINANCIAL INFORMATION ITEM 1 FINANCIAL STATEMENTS F-1 ITEM 2 MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIALNDITION AND RESULTS OF OPERATIONS 3 ITEM 3 QUANTITATIVE AND QUALITATIVE DISCLOSURESOUT MARKET RISK 20 ITEM 4NTROLS AND PROCEDURE 20 PART II - OTHER INFORMATION ITEM 1 LEGAL PROCEEDINGS] [Certifications I, Gang, Li, certify that: 1. I have reviewed this quarterly report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [Certifications I, Lihua Wang, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of NF Energyvingrporation. 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended June 30, 2013. NF Energyvingrporation Gang Li ( v352631_ex32-1.htm 4 EX-32.1] [SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2)The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany for the period ended June 30, 2013. NF Energyvingrporation August 14, 2013 Lihua, Wang Principal Financial and Accounting Officer)]

By info| 2016-02-08T07:07:51+00:00 August 14th, 2013|Categories: Chinese Stocks, NFEC, Webplus ver|Tags: 0001213660, 10-Q, 2013-08-14, 3490, MISCELLANEOUS FABRICATED METAL PRODUCTS, NFEC|0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 10-Q: (Original Filing)

[] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Weibing Lu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Bing Mei, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Skystar Bio-Pharmaceutical Company; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. August 14, 2013 Weibing Lu Chief Executive Officer] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. August 14, 2013 Bing Mei Chief Financial Officer]

By info| 2016-03-01T04:16:53+00:00 August 14th, 2013|Categories: Chinese Stocks, SEC Original, SKBI|Tags: 0001076939, 10-Q, 2013-08-14, 2834, PHARMACEUTICAL PREPARATIONS, SKBI|0 Comments

EVK [Ever-Glory International,] NT 10-Q: (Original Filing)

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): o o o x o o June 30, 2013 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing checked]

By info| 2016-03-02T15:04:34+00:00 August 14th, 2013|Categories: Chinese Stocks, EVK, SEC Original|Tags: 0000943184, 2013-08-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK, NT_10-Q|0 Comments

EVK [Ever-Glory International,] NT 10-Q: FORM 12b-25 NOTIFICATION OF LATE FILING (Check One):

[FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): o o o x o o June 30, 2013 For Period Ended: o o o o o For the Transition Period Ended: ________________________ Nothing in this form shall be construed to imply that the Commission has verified any information contained herein. If the notification relates to a portion of the filing checked]

By info| 2016-03-02T15:05:31+00:00 August 14th, 2013|Categories: Chinese Stocks, EVK, Webplus ver|Tags: 0000943184, 2013-08-14, 2300, APPAREL and OTHER FINISHED PRODS OF FABRICS and SIMILAR MATERIAL, EVK, NT_10-Q|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321063013.htm]

By info| 2016-03-03T16:51:45+00:00 August 14th, 2013|Categories: Chinese Stocks, CPHI, SEC Original|Tags: 0001106644, 10-Q, 2013-08-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CLNT [Cleantech Solutions International,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x For the quarterly period ended June 30, 2013 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, NEVADA 90-0648920 (State or other jurisdiction of (I.R.S. Employerorporation of organization) Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1. 2. 3. 4. a) b) designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICERRBANES-OXLEY ACT OF 2002 I,am Wasserman, certify that: 1. 2. 3. 4. a) b) designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial reporting and the preparation of financial statements for external] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jianhua Wu ChiefExecutive Officeram Wasserman ChiefFinancial Officer (Principal Accounting Officer) SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER]

By info| 2016-02-02T22:18:16+00:00 August 14th, 2013|Categories: Chinese Stocks, CLNT, SEC Original|Tags: 0000819926, 10-Q, 2013-08-14, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

JKS [JinkoSolar] 6-K: (Original Filing)

[JinkoSolar Announces Second Quarter 2013 Financial Results SHANGHAI, China, August 14, 2013 - Second Quarter 2013 Highlights Total solar product shipments were 489.2megawatts (MW),nsisting of 460.0MW of solar modules, 11.1MW of silicon wafers and 18.1MW of solar cells. This represents anrease of 44.5% from 338.6 MW in the first quarter of 2013 and anrease of]

By info| 2016-02-15T01:13:43+00:00 August 14th, 2013|Categories: Chinese Stocks, JKS, SEC Original|Tags: 0001481513, 2013-08-14, 3674, 6-K, JKS, SEMICONDUCTORS and RELATED DEVICES|0 Comments

CPHI [CHINA PHARMAS,] 10-Q: FORM 10-Q (Mark One) x June 30, 2013

[FORM 10-Q (Mark One) x June 30, 2013 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMA HOLDINGS, INC Nevada 73-1564807 (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China 570216 +86- 898-6681-1730 (China) (Issuer's telephone number, including area code)] [CERTIFICATION OF OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 1. I have reviewed this report on Form 10-Q of China Pharma Holdings, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made,] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Dated: August 14, 2013 President and Chief Executive Officer (principal financial officer and principal accounting officer) EX-32.1 4 cphi10qex321063013.htm]

By info| 2016-03-03T16:54:46+00:00 August 14th, 2013|Categories: Chinese Stocks, CPHI, Webplus ver|Tags: 0001106644, 10-Q, 2013-08-14, 2834, CPHI, PHARMACEUTICAL PREPARATIONS|0 Comments

CLNT [Cleantech Solutions International,] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended June 30, 2013 o For the transition period from __________ to __________ CLEANTECH SOLUTIONS INTERNATIONAL, NEVADA 90-0648920 (State or other jurisdiction of (I.R.S. Employerorporation of organization) Identification No.) No. 9 Yanyu Middle Road Qianzhou Village, Huishan District, Wuxi City] [SARBANES-OXLEY ACT OF 2002 I, Jianhua Wu, certify that: 1. 2. 3. 4. a) b) designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally] [CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICERRBANES-OXLEY ACT OF 2002 I,am Wasserman, certify that: 1. 2. 3. 4. a) b) designed such internalntrol over financial reporting, orused such internalntrol over financial reporting to be designed under our supervision, to provide reasonablesurance regarding the reliability of financial reporting and the preparation of financial statements for external] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (1) (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany. Jianhua Wu ChiefExecutive Officeram Wasserman ChiefFinancial Officer (Principal Accounting Officer) SECTION 1350 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER]

By info| 2016-02-02T22:19:03+00:00 August 14th, 2013|Categories: Chinese Stocks, CLNT, Webplus ver|Tags: 0000819926, 10-Q, 2013-08-14, 3550, CLNT, SPECIAL INDUSTRY MACHINERY (NO METALWORKING MACHINERY)|0 Comments

JKS [JinkoSolar] 6-K: JinkoSolar Announces Second Quarter 2013 Financial Results SHANGHAI,

[JinkoSolar Announces Second Quarter 2013 Financial Results SHANGHAI, China, August 14, 2013 - Second Quarter 2013 Highlights Total solar product shipments were 489.2megawatts (MW),nsisting of 460.0MW of solar modules, 11.1MW of silicon wafers and 18.1MW of solar cells. This represents anrease of 44.5% from 338.6 MW in the first quarter of 2013 and anrease of]

By info| 2016-02-15T01:16:01+00:00 August 14th, 2013|Categories: Chinese Stocks, JKS, Webplus ver|Tags: 0001481513, 2013-08-14, 3674, 6-K, JKS, SEMICONDUCTORS and RELATED DEVICES|0 Comments